The Future of Psychedelic Medicine
Using a foundation of evidence-informed research, we want to empower people to achieve their potential and thrive.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
People globally are affected by a form of depression.
Dollars lost annually in global workforce productivity due to depression and anxiety.
Formulas standardized across clinical studies of psychedelic compounds.
Havn Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Westwood Institute founder, Dr. Marvin Westwood will work with Havn Life’s research team to develop best practices for combining therapy and psychedelic interventions for veterans. …
Havn Life has joined the UK-based Conservative Drug Policy Reform Group (CDPRG), a group organized to benefit drug policy-making The Havn Life Advisory Board adds …
Vancouver, BC – Havn Life Sciences Inc. (CSE : HAVN) (FSE : 5NP) (the “Company” or “Havn Life”) is pleased to announce that 10,927,856 common …